Bristol-Myers Squibb Company (BVL:BMY)

Peru flag Peru · Delayed Price · Currency is PEN · Price in USD
46.60
0.00 (0.00%)
At close: Sep 22, 2025
Market Cap315.15B
Revenue (ttm)168.86B
Net Income (ttm)17.87B
Shares Outn/a
EPS (ttm)8.80
PE Ratio17.63
Forward PE6.87
Dividend9.05 (19.43%)
Ex-Dividend DateJul 3, 2025
Volumen/a
Average Volume20
Openn/a
Previous Close46.60
Day's Rangen/a
52-Week Range46.11 - 59.85
Betan/a
RSI57.42
Earnings DateOct 30, 2025

About BVL:BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Lima Stock Exchange
Ticker Symbol BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.